KAZAKH ADAPTATION OF THE MONTREAL COGNITIVE ASSESSMENT (MOCA)
Utegenova A. Utepkaliyeva A. Kabdrakhmanova G. Khamidulla A. Seitmaganbetova N.
April 2022Georgian Association of Business Press
Georgian Medical News
2022#325Issue 417 - 20 pp.
Objective. The Montreal Cognitive Assessment (MoCA) is a brief cognitive evaluation tool that has been developed for screening of patients for Mild Cognitive Impairment (MCI). MCI is a recognized high-risk state for Alzheimers disease development. The aim of the present study was to create a Kazakh-language adaptation of the original version of the Montreal Cognitive Assessment (version 7.1) and evaluate its reliability by determining internal consistency using the Cronbachs alpha coefficient. Materials and methods. This prospective study involved 50 patients diagnosed with Parkinsons disease in accordance with the 2015 MDS clinical criteria with diagnosed MCI according to clinical guidelines of the Movement disorder society (MDS). Clinical and neuropsychological evaluation were carried out on all patients. Results. The internal consistency and reliability of the translated scale were investigated by means of the Cronbach alpha coefficient. The Cronbachs alpha coefficient for the MoCA Kazakh version was 0.77. Conclusion. While the evaluation of discriminatory validity was not performed in this study, the Kazakh adaptation of the MoCA was shown to be a reliable tool for screening MCI among patients with Parkinsons Disease.
cognitive assessment , mild cognitive impairment , MoCA , neuropsychologicaltests , neuropsychology
Text of the article Перейти на текст статьи
West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
West Kazakhstan Marat Ospanov Medical University
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026